Akebia draws $9.3M net from extended loan tranche; issues warrant for 1.15M shares

Akebia Therapeutics, Inc.

Extended Tranche C expiry from Dec 31, 2024 to Feb 3, 2025; interest accrues from Dec 31, 2024.
Drew $10M Tranche C on Feb 3, 2025; net proceeds of $9.3M after debt issuance costs and interest.
Issued warrant to Kreos Capital affiliate for 1,153,846 shares at $1.30 exercise, 8-year term.
Warrant not registered; relies on Section 4(a)(2) and Rule 506(b) exemption.
Loan facility total $55M; prior tranches of $37M and $8M already drawn.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.